Bausch Health
236 hedge funds and large institutions have $1.64B invested in Bausch Health in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 85 increasing their positions, 51 reducing their positions, and 29 closing their positions.
76% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 29
67% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 51
8% more funds holding
Funds holding: 219 → 236 (+17)
6% more capital invested
Capital invested by funds: $1.56B → $1.64B (+$87.2M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
1.39% less ownership
Funds ownership: 65.02% → 63.63% (-1.4%)
52% less call options, than puts
Call options by funds: $15.8M | Put options by funds: $33.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$16.6M |
| 2 |
PC
Paulson & Co
New York
|
+$16.4M |
| 3 |
Goldman Sachs
New York
|
+$13.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$9.6M |
| 5 |
Millennium Management
New York
|
+$8.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$46.1M |
| 2 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$29.9M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$29.9M |
| 4 |
MSE
MUFG Securities EMEA
London,
United Kingdom
|
-$21.9M |
| 5 |
SG Americas Securities
New York
|
-$19.4M |
BHC Hedge Fund Activity: Q4 2025 in Review
236 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q4 2025, worth a combined $1.64B — up 5.6% from $1.56B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new BHC positions and 29 closed out — a net gain of 22 holders — while 85 added to existing stakes and 51 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $16.6M. The largest seller was Nomura Holdings, cutting an estimated $46.1M.
- 236 institutional investors held Bausch Health (BHC) as of Q4 2025, up from 219 in Q3 2025.
- Funds reported $1.64B of Bausch Health stock for Q4 2025, up 5.6% quarter-over-quarter.
- 51 funds opened new Bausch Health positions in Q4 2025 and 29 closed out, a net change of +22 holders.
- The largest Bausch Health buyer in Q4 2025 was Arrowstreet Capital, an estimated $16.6M added.
- The largest Bausch Health seller in Q4 2025 was Nomura Holdings, an estimated $46.1M sold.
Based on aggregated 13F filings for Q4 2025.